Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cipla
McKesson
US Department of Justice
Chubb
Cerilliant
Deloitte
McKinsey
Cantor Fitzgerald

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020402

« Back to Dashboard

NDA 020402 describes ADVIL MIGRAINE LIQUI-GELS, which is a drug marketed by Pfizer and is included in one NDA. It is available from four suppliers. Additional details are available on the ADVIL MIGRAINE LIQUI-GELS profile page.

The generic ingredient in ADVIL MIGRAINE LIQUI-GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-six suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020402
Tradename:ADVIL MIGRAINE LIQUI-GELS
Applicant:Pfizer
Ingredient:ibuprofen
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020402
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADVIL LIQUI-GELS ibuprofen CAPSULE;ORAL 020402 NDA Wyeth Consumer Healthcare LLC 0573-0149 0573-0149-04 2 PACKET in 1 BLISTER PACK (0573-0149-04) > 2 CAPSULE, LIQUID FILLED in 1 PACKET
ADVIL LIQUI-GELS ibuprofen CAPSULE;ORAL 020402 NDA Wyeth Consumer Healthcare LLC 0573-0149 0573-0149-13 1 BOTTLE in 1 CARTON (0573-0149-13) > 80 CAPSULE, LIQUID FILLED in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrengthEQ 200MG FREE ACID AND POTASSIUM SALT
Approval Date:Apr 20, 1995TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrengthEQ 200MG FREE ACID AND POTASSIUM SALT
Approval Date:Mar 16, 2000TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Baxter
Chubb
Chinese Patent Office
Medtronic
Federal Trade Commission
Argus Health
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.